Fractionated high-dose-rate brachytherapy in the management of uterine cervical cancer

Yonsei Medical Journal

Volumn 43, Issue 6, 2002, Pages 737-748

  Park, Hee Chul ^a   Suh, Chang Ok ^a   Kim, Gwi Eon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Brachytherapy; Cervical cancer; High dose rate; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; COBALT 60; IRIDIUM 192;

BLADDER DISEASE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COBALT THERAPY; CONTROLLED STUDY; ENDOCAVITARY RADIOTHERAPY; ENTEROPATHY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; MEDICAL TECHNOLOGY; RADIATION DOSE FRACTIONATION; REVIEW; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TREATMENT PLANNING; UTERINE CERVIX CANCER;

EID: 0036953716     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2002.43.6.737     Document Type: Review

References (34)

1. Orton CG. High and low dose-rate brachytherapy for cervical carcinoma. Acta Oncol 1998;37:117-25.
2. Henschke UK, Hilaris BS, Mahan DG. Remote afterloading with intracavitary applicators. Radiology 1964;83:344-5.
3. Henschke UK, Hilaris BS, Mahan DG. Intracavitary radiation therapy of the uterine cancer by remote afterloading with cycling sources. Am J Roentgenol 1966;96:45-51.
4. O'Connell D, Howard N, Joslin CA, Ramsey NW, Liversage WE. A new remotely controlled unit for the treatment of uterine cancer. Lancet 1965;18:570-1.
5. Nag S, Orton C, Young D, Erickson B. The American Brachytherapy Society survey of brachytherapy practice for carcinoma of the cervix in the United States. Gynecol Oncol 1999;73:111-8.
6. Kim GE, Suh CO, Lee DH, Park CY. Treatment for uterine cervical cancer using high-dose-rate Co-60 sources. J Korean Soc Ther Radiol Oncol 1983;1:95-102.
7. Suh CO, Kim GE, Loh JJK. Treatment of carcinoma of the uterine cervix with high-dose-rate intracavitary irradiation using Ralstron. J Korean Soc Ther Radiol Oncol 1990;8:231-9.
8. Huh SJ. Current status of high dose rate brachytherapy in cervical cancer in Korea and optimal treatment schedule. J Korean Soc Ther Radiol Oncol 1998;16: 357-66.
9. Arai T, Morita S, Linuma T. Radiotherapy for cancer of the uterine cervix using HDR remote afterloading system. Determination of the optimal fractionation. Clin Cancer Treat(Jpn) 1979;25:605-12.
10. Shikematsu Y, Nishyama K, Masaki N, Inoue T, Miyata Y, Ikeda H, et al. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose rate: A comparative study with a low-dose rate system. Int J Radiat Oncol Biol Phys 1983;9:351-6.
11. Kim WC, Kim GE, Suh CO, Loh JJK. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix. Jpn J Clin Oncol 2001;31:432-7.
12. Deehan C, O'Donoghue JA. Biological equivalence of LDR and HDR brachytherapy. In: Mould RF, Battermann JJ, Martinez AA, Speiser BL, editors. Brachytherapy from radium to optimization. Leersum, The Netherlands: Nucletron International BV; 1994. p.19-35.
13. Hall EJ, Brenner DJ. Sublethal damage-repair rates: a new tool for improving therapeutic ratios? Int J Radiat Oncol Biol Phys 1994;30:241-2.
14. Orton CG. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells. Int J Radiat Oncol Biol Phys 2001;49:183-9.
15. Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys 1999;43:359-66,
16. Moon CW, Jeung TS, Yum HY. Analysis of radiotherapy associated factors in stage IIB carcinoma of uterine cervix. J Korean Soc Ther Radiol Oncol 1990;8: 241-54.
17. Kim OB, Choi TJ, Kim JH, Lee HJ, Kim YA, Suh YW, et al. Carcinoma of uterine cervix treated with high dose rate intracavitary irradiation: 1. Pattern of failure. J Korean Soc Ther Radiol Oncol 1993;11:369-76.
18. Kim JC, Park IK. Comparison of the result of radiation alone and chemoradiation in cervical cancer. J Korean Soc Ther Radiol Oncol 1995;13:191-8.
19. Kim JH, Youn SM, Kim OB. Hydroxyurea with radiation therapy of the carcinoma of the cervix IIA, IIB. J Korean Soc Ther Radiol Oncol 1995;13:369-75.
20. Choi DH, Huh SJ. Radiotherapy results of early cervix cancer. J Korean Soc Ther Radiol Oncol 1996;14:33-9.
21. Kim ES, Choi DH, Huh SJ. Radiotherapy results of uterine cervix cancer stage IIB: Overall survival, prognostic factors, patterns of failure and late complications. J Korean Soc Ther Radiol Oncol 1998;16:1-11.
22. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Steven RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-43.
23. Rose PG, Bundy BN, Watkind EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.
24. Chao KSC, Williamson JF, Grigsby PW, Perez CA. Uterosacral space involvement in locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1998;40:397-403.
25. Lee SW, Suh CO, Chung EJ, Kim GE. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma. Int J Radiat Oncol Biol Phys 2002;52:1338-44.
26. Chung EJ, Kim GE, Suh CO, Keum KC, Kim WC. Late rectal complication in patients treated with high dose rate brachytherapy for stage IIB carcinoma of the cervix. J Korean Soc Ther Radiol Oncol 1996;14:41-52.
27. Orton CG, Seyedsadr M, Somnay A. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys 1991;21:1425-34.
28. Orton CG. Width of the therapeutic window: What is the optimal dose-per fraction for high dose rate cervix cancer brachytherapy? Int J Radiat Oncol Biol Phys 1991;31:1011-3.
29. Clark BG, Souhami L, Roman TN, Chappell R, Evans MDC, Fowler JF. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1997;38:989-93.
30. Eifel PJ, Thoms WW Jr, Smith TL, Morris M, Oswald MJ. The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone. Int J Radiat Oncol Biol Phys 1994;28:113-8.
31. Eifel PJ, Morris M, Wharton JT, Oswald MJ. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994;29:9-16.
32. International Commission on Radiation Units and Measurements. Dose and volume specifications for reporting intracavitary therapy in gynecology. (vol 38) Bethesda, MD: International Commission on Radiation Units and Measurement; 1985. p.1-23.
33. Ling CC, Schell MC, Working KR, Jentzsch K, Harisiadis L, Carabell S, et al. CT-assisted assessment of bladder and rectum dose in gynecological implants. Int J Radiat Oncol Biol Phys 1987;13:1577-82.
34. Schoeppel SL, Fraass BA, Hopkins MP, La Vigne ML, Lichter AS, McShan DL, et al. A CT-compatible version of the Fletcher system intracavitary applicator: clinical application and 3-dimensional treatment planning. Int J Radiat Oncol Biol Phys 1989;17:1103-9.